Clinical trials
Completed Observational Urinary Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
144 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2004 | 5 |
| 2005 | 6 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 8 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 12 |
| 2017 | 13 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 14 |
| 2021 | 15 |
| 2022 | 8 |
| 2023 | 11 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 144 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| UNC Lineberger Comprehensive Cancer Center | 5 |
| University of Kansas Medical Center | 5 |
| AstraZeneca | 4 |
| Jørgen Bjerggaard Jensen | 3 |
| M.D. Anderson Cancer Center | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Ain Shams University | 2 |
| Ankara Etlik City Hospital | 2 |
| Baylor College of Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 144 |
| Lung Neoplasms | 18 |
| Prostatic Neoplasms | 14 |
| Breast Neoplasms | 13 |
| Neoplasms | 13 |
| Pancreatic Neoplasms | 13 |
| Kidney Neoplasms | 12 |
| Stomach Neoplasms | 11 |
| Carcinoma, Renal Cell | 10 |
| Carcinoma, Transitional Cell | 10 |
Trials
Showing 1 to 25 of 144. Each trial links to its page on Pharma Observatory.
44 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.